Market revenue in 2022 | USD 2.0 million |
Market revenue in 2030 | USD 4.2 million |
Growth rate | 10% (CAGR from 2022 to 2030) |
Largest segment | Blood culture media |
Fastest growing segment | Assay Kits & Reagents |
Historical data | 2018 - 2021 |
Base year | 2022 |
Forecast period | 2023 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Instruments, Blood Culture Media, Assay Kits & Reagents, Software |
Key market players worldwide | BD, BioMerieux SA, Thermo Fisher Scientific Inc, Danaher Corp, Roche Holding AG ADR, Luminex, Koninklijke Philips NV, Bruker Corp, Cepheid, Immunexpress |
Blood culture media was the largest segment with a revenue share of 40% in 2022. Horizon Databook has segmented the Thailand sepsis diagnostics market based on instruments, blood culture media, assay kits & reagents, software covering the revenue growth of each sub-segment from 2018 to 2030.
Sepsis represents a major public health challenge in Thailand, marked by a high incidence and substantial mortality rates. Addressing this issue requires the development & implementation of effective diagnostic tools to enhance patient outcomes and alleviate the overall burden of the condition.
The data from the National Library of Medicine reveals that the incidence of septic arthritis, a common complication of sepsis, exhibited a slight increase from 2018 to 2019.
These tests, generally performed in hospital laboratories, can face limitations in accessibility, particularly in rural or remote regions. Hence, there is a pressing need for more effective point-of-care diagnostic tools that can be utilized in primary care & emergency settings to facilitate early detection and prompt treatment of sepsis.
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account